((1aR,7aS,10aS,10bS,E)-1a-methyl-8-methylene-9-oxo-1a,2,3,6,7,7a,8,9,10a,10b-decahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-5-yl)methyl 2-(5-fluoro-2,4-dioxo-3-(4-(trifluoromethyl)benzyl)-3,4-dihydropyrimidin-1(2H)-yl)acetate

ID: ALA4535367

PubChem CID: 155547995

Max Phase: Preclinical

Molecular Formula: C29H28F4N2O7

Molecular Weight: 592.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)Cn1cc(F)c(=O)n(Cc3ccc(C(F)(F)F)cc3)c1=O)=C\CC[C@@]1(C)O[C@@H]21

Standard InChI:  InChI=1S/C29H28F4N2O7/c1-16-20-10-7-18(4-3-11-28(2)24(42-28)23(20)41-26(16)38)15-40-22(36)14-34-13-21(30)25(37)35(27(34)39)12-17-5-8-19(9-6-17)29(31,32)33/h4-6,8-9,13,20,23-24H,1,3,7,10-12,14-15H2,2H3/b18-4+/t20-,23-,24-,28+/m0/s1

Standard InChI Key:  ZNQPEKZCMNHWNW-QJTHHPEESA-N

Molfile:  

 
     RDKit          2D

 45 49  0  0  0  0  0  0  0  0999 V2000
   15.5972   -8.1048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.0486   -7.4237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2316   -7.3723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8569   -9.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4847   -8.8937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1612   -8.9873    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3588   -8.1914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1728   -8.1323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3682   -7.3399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6778   -6.9050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6516   -6.0787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8555   -6.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9891   -5.5851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1910   -5.7973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3760   -5.7006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0657   -6.1389    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7901   -5.7607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8249   -4.9443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5526   -7.8307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9774   -6.6059    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   18.2782   -9.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9833   -8.0628    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   16.9146  -10.2365    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6760   -8.5640    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   19.4798   -6.1990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2043   -5.8209    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8915   -6.2619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6137   -5.8871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6526   -5.0705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9632   -4.6300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2347   -5.0062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5449   -4.5681    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3785   -4.6951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3017   -6.3280    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.0007   -3.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7264   -3.4380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4136   -3.8821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1388   -3.5071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1768   -2.6899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4837   -2.2492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7613   -2.6267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9021   -2.3133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5908   -2.7530    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.9385   -1.4969    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.6065   -1.8985    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  1  0
  5  8  1  0
  7  6  1  0
  6  4  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2  7  1  0
 10 11  1  0
  3 12  1  0
 11 13  2  0
 12 14  1  0
 13 14  1  0
 11 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
  3 19  1  1
  2 20  1  1
  5 21  2  0
  8 22  1  6
  4 23  2  0
  7 24  1  1
 17 25  1  0
 25 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 29 33  2  0
 28 34  1  0
 30 35  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 36  1  0
 39 42  1  0
 42 43  1  0
 42 44  1  0
 42 45  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4535367

    ---

Associated Targets(Human)

Bel7402/5-FU (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bel-7402 (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 592.54Molecular Weight (Monoisotopic): 592.1833AlogP: 3.52#Rotatable Bonds: 6
Polar Surface Area: 109.13Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.33CX LogD: 4.33
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.17Np Likeness Score: 0.74

References

1. Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q..  (2019)  Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.,  183  [PMID:31553932] [10.1016/j.ejmech.2019.111706]

Source